Filter
640
Text search:
Hepatitis
c
virus
during
pregnancy
Featured
Recommendations
84
New Publications
208
Language
Document type
No document type
438
Guidelines
102
Studies & Reports
50
Manuals
22
Strategic & Response Plan
13
Fact sheets
6
Training Material
5
Situation Updates
3
Online Courses
1
Countries / Regions
India
40
Tanzania
22
Nepal
21
South Africa
19
Kenya
18
Global
18
Nigeria
17
Zambia
14
Bangladesh
11
Namibia
11
Philippines
10
Rwanda
10
Western and Central Europe
10
Sierra Leone
8
Liberia
8
Malawi
8
Ethiopia
7
Latin America and the Carribbean
7
Asia
7
Russia
7
Uganda
6
Indonesia
6
Lesotho
6
Eswatini/ Swaziland
5
Ukraine
5
Myanmar / Burma
5
Africa
5
Ghana
4
Cambodia
4
South–East Asia Region
4
Eastern Europe
4
Georgia
4
Zimbabwe
3
Albania
3
Cameroon
2
Pakistan
2
South Sudan
2
Germany
2
Botswana
2
Tajikistan
2
Moldova
2
USA
1
Afghanistan
1
Thailand
1
Gambia
1
Mozambique
1
Papua New Guinea
1
Dominican Republic
1
Brazil
1
North Macedonia
1
Sri Lanka
1
Bhutan
1
Venezuela
1
Armenia
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
260
Clinical Guidelines
96
Women & Child Health
41
Public Health
18
Capacity Building
14
Key Resources
10
Pharmacy & Technologies
7
Toolboxes
HIV
160
TB
33
COVID-19
17
Refugee
16
Rapid Response
13
Pharmacy
13
Mental Health
12
Caregiver
12
NTDs
12
Ebola
7
Zika
6
Global Health Education
6
NCDs
5
Natural Hazards
4
Planetary Health
4
Conflict
3
AMR
3
Health Financing Toolbox
2
Disability
1
Polio
1
South Sudan
1
The five hepatitis viruses have different epidemiological profiles, and their impact, duration, and transmission route also vary. The most common transmission routes contributing to the spread of hepatitis
...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis
...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the
...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera
...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated t
...
Technical report
This manual aims to provide information about the methods for investigating outbreaks of hepatitis E, and measures for their prevention and control. In addition, the manual gives information about the causative agent – known ...
This manual aims to provide information about the methods for investigating outbreaks of hepatitis E, and measures for their prevention and control. In addition, the manual gives information about the causative agent – known ...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment cri
...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited
...
